Psoriatic arthritis (PsA) is a complex inflammatory disease with heterogeneous clinical
features, which complicates psoriasis in 30% of patients. There are no diagnostic criteria or …

Psoriatic arthritis (PsA) is a chronic inflammatory disease primarily affecting peripheral and
axial joints, with the possible presence of extra-articular manifestations (EAMs), such as …

Background Guselkumab was efficacious in reducing signs and symptoms of psoriatic
arthritis in the phase 3 DISCOVER-1 and DISCOVER-2 studies. We aimed to evaluate the …

Objectives To examine associations between PsA and psoriasis vs lifestyle factors and
comorbidities by triangulating observational and genetic evidence. Methods We analysed …

Objective This study aimed to develop a risk of psoriatic arthritis (PsA) predictive model for
plaque psoriasis patients based on the available features. Methods Patients with plaque …

Objectives: Knowledge of the correspondence between clinical ICD diagnoses and
classification criteria fulfilment is crucial to interpret studies identifying cases via ICD codes …

Objective Psoriatic disease remains underdiagnosed and undertreated. We developed and
validated a suite of novel, sensor-based smartphone assessments (Psorcast app) that can …

Objective Inhibitors of the interleukin 13 (IL‐13) pathway, such as dupilumab, are licensed
for atopic dermatitis and asthma. Adverse events resembling psoriatic disease after …

Abstract Purpose of Review To provide an overview of the ultrasound (US) studies focusing
on enthesitis in psoriatic arthritis (PsA). Recent Findings Last-generation US equipment has …

Objective Real-world secukinumab gastrointestinal-related adverse events (GIRAE) data
during treatment for AS and PsA are lacking. We aimed to obtain this through baseline …